Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Anaerobe. 2021 Dec;72:102446. doi: 10.1016/j.anaerobe.2021.102446. Epub 2021 Sep 11.
The anaerobic infection management is usually based on empirical treatment because anaerobic culture techniques take a long time due to their fastidious nature. The aim of this study was to analyze the etiological profile of severe anaerobic infections and AST data from clinical anaerobic bacteria isolated in a tertiary hospital in Madrid (Spain).
A consecutive study was carried out over 19 months in Ramón y Cajal Universitary Hospital, Madrid. Clinical samples were processed in appropriate anaerobic media and incubated using Anoxomat system. Identification was performed by MALDI-TOF. AST were determined with gradient diffusion method using EUCAST (penicillin, co-amoxiclav, imipenem, clindamycine and metronidazole) or CLSI (cefoxitin) breakpoints.
During the period of study, 503 anaerobic microorganisms isolated from 424 clinical samples were included. Twenty-six percent of the cultures were monomicrobial, while 70.0% also contained aerobic bacteria. The most common source of infection was abscesses (26%), while blood infections represented the 11%. Anaerobic gram-negative bacilli were predominant (41%), being Bacteroides fragilis (13%) the most prevalent overall; anaerobic gram-positive bacilli represented 35%, anaerobic gram-positive cocci 19% and anaerobic gram-negative cocci 5%. Metronidazole and imipenem were the most effective agents tested against anaerobic bacteria, while clindamycin presented higher resistance rates.
Antimicrobial susceptibility surveillance of anaerobic bacteria should be performed to monitor changes in resistance patterns and to be able to optimize empiric antimicrobial treatment. Reliable species identification and quick reporting of results would guide clinicians to select the optimal antimicrobial therapy.
由于厌氧菌培养技术较为复杂,耗时较长,因此通常基于经验治疗来进行厌氧感染管理。本研究旨在分析马德里一家三级医院临床分离的严重厌氧菌感染的病原谱和 AST 数据。
在马德里 Ramón y Cajal 大学医院进行了为期 19 个月的连续研究。临床样本在适当的厌氧培养基中进行处理,并使用 Anoxomat 系统进行孵育。通过 MALDI-TOF 进行鉴定。AST 采用梯度扩散法,根据 EUCAST(青霉素、复方新诺明、亚胺培南、克林霉素和甲硝唑)或 CLSI(头孢西丁)折点进行测定。
在研究期间,从 424 份临床样本中分离出 503 株厌氧菌。26%的培养物为单培养物,而 70.0%的培养物还含有需氧菌。感染最常见的来源是脓肿(26%),而血液感染占 11%。厌氧革兰氏阴性杆菌占优势(41%),其中脆弱拟杆菌(13%)总体最为常见;厌氧革兰氏阳性杆菌占 35%,厌氧革兰氏阳性球菌占 19%,厌氧革兰氏阴性球菌占 5%。甲硝唑和亚胺培南是对厌氧菌最有效的试验药物,而克林霉素的耐药率较高。
应进行厌氧菌的药敏监测,以监测耐药模式的变化,并能够优化经验性抗菌治疗。可靠的菌种鉴定和快速报告结果将指导临床医生选择最佳的抗菌治疗。